SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...
TEL AVIV, Israel & SAN JOSE, Calif.--(BUSINESS WIRE)--RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, announced today a ...
SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...
Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...
Continuous advances in artificial intelligence promise to shake up medical care in all kinds of exciting ways, with the ability to rapidly scan medical images and spot signs of disease far more ...
The tool may potentially be used to help guide decisions about who to screen for prostate cancer and at what age, according to the study published in the journal BMJ. At present, detection of prostate ...
The low light detector solutions provider, SensL, announce their involvement in developing a new medical imaging tool for prostate cancer biopsies. This specialized prostate biopsy guidance tool is ...
The researchers used genome-wide association studies (GWAS) to determine whether a man’s genetic predisposition to developing prostate cancer could be used to predict his risk of developing the ...
An online decision tool helps men diagnosed with prostate cancer sort through an intimidating flurry of possible treatments and customize treatment plans of their own, according to a study. An online ...
Tá torthaí a d'fhéadfadh a bheith dorochtana agat á dtaispeáint faoi láthair.
Folaigh torthaí dorochtana
Aiseolas